6.64
1.22%
+0.08
Pre-mercato:
6.64
Ironwood Pharmaceuticals Inc Azioni (IRWD) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
3.35%
117.55
|
113.74 | 107.38 | 104.06 | 107.20 |
Operating Expenses
|
8.48%
79.96
|
73.72 | 1,190.52 | 43.96 | 38.84 |
Interest Income/Expense |
14.39%
8.423
|
9.839 | 1.84 | 1.527 | 1.526 |
Benefits Costs and Expenses |
19.55%
119.30
|
99.79 | 1,196.86 | 58.35 | 38.84 |
Costs And Expenses |
8.48%
79.96
|
73.72 | 1,190.52 | 43.96 | 38.84 |
Operating Income/Loss |
6.08%
37.59
|
40.02 | -1,083.14 | 60.10 | 68.36 |
Nonoperating Income/Loss |
10.65%
-7.229
|
-8.091 | 6.917 | 5.764 | 3.902 |
Income/Loss From Continuing Operations Before Tax |
105.46%
-1.745
|
31.93 | -1,076.22 | 65.86 | 68.36 |
Income Tax Expense/Benefit |
78.54%
32.10
|
17.98 | 13.26 | 20.15 | 23.40 |
Income/Loss From Continuing Operations After Tax |
112.51%
-1.745
|
13.95 | -1,089.48 | 45.71 | 48.87 |
Net Income/Loss
|
112.51%
-1.745
|
13.95 | -1,089.48 | 45.71 | 48.87 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
52.01%
-0.658
|
-1.371 | -27.29 | - | - |
Basic Average Shares |
99.87%
0.195
|
155.89 | 155.37 | 154.45 | -0.347 |
Diluted Average Shares |
99.90%
0.195
|
186.89 | 155.37 | 186.68 | -0.192 |
Basic Earnings Per Share |
110.00%
-0.01
|
0.10 | -6.84 | 0.30 | 0.32 |
Diluted Earnings Per Share |
111.11%
-0.01
|
0.09 | -6.84 | 0.25 | 0.27 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):